| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 9 |
| 1 | MYCOPHENOLATE MOFETIL | 9 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 9 |
| 3 | RUXOLITINIB | 9 |
| 4 | AZITHROMYCIN DIHYDRATE | 6 |
| 5 | AZITHROMYCIN | 5 |
| 6 | AZITHROMYCIN MONOHYDRATE | 5 |
| 7 | FLUCONAZOLE | 5 |
| 8 | INFLIXIMAB | 5 |
| 9 | LAMIVUDINE ORAL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLOPATADINE HCL | 1 | 0.0027 |
| 1 | RIFABUTIN | 5 | 0.0018 |
| 2 | ETHAMBUTOL HYDROCHLORIDE | 4 | 0.0015 |
| 3 | ALDESLEUKIN | 1 | 0.0008 |
| 4 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 5 | LAMIVUDINE | 9 | 0.0004 |
| 6 | BARICITINIB | 1 | 0.0003 |
| 7 | PYRAZINAMIDE | 3 | 0.0003 |
| 8 | LOPINAVIR AND RITONAVIR | 4 | 0.0003 |
| 9 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 5 | 0.0014 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 4 | Antimycobacterial [EPC] | 4 | 0.0002 |
| 5 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0001 |
| 9 | Sulfone [EPC] | 1 | 0.0001 |